journal
Journals Blood Coagulation & Fibrinolys...

Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis

https://read.qxmd.com/read/38305129/hereditary-factor-x-deficiency-in-america-survey-impact-on-quality-of-life-and-burden-of-disease-in-patients-and-caregivers
#21
JOURNAL ARTICLE
Brian Branchford, Kim Clark, Richard H Stanford, Denise A Garner, Shirley P Huang, Eric Wolford
UNLABELLED: Hereditary factor X deficiency (HFXD) is a rare bleeding disorder causing delayed haemostasis and potentially life-threatening bleeds. Patient/caregiver burden and diagnosis path have not been well characterized. THE AIM OF THIS STUDY WAS TO: describe the diagnosis path, disease burden, and HFXD impact on quality of life (QoL) in patients and caregivers.This was a prospective, cross-sectional, web-based survey of patients with HFXD and caregivers addressing the patient/caregiver experience, QoL, humanistic and unmet needs...
February 3, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38305104/the-link-between-high-factor-viii-to-protein-c-ratio-values-and-poor-liver-function-after-major-hepatectomy
#22
JOURNAL ARTICLE
Patricia Duque, Jose María Perez-Peña, Lleimi Alarcon-Perez, Luis Olmedilla, Jesús Alberto Varela, Cristina Pascual, Ana María Rodriguez-Huerta, José Manuel Asencio, Jose Ángel Lopez-Baena, Ignacio Garutti
Our goal was to assess the coagulation profile in the immediate postoperative time after major liver surgery and its association with the liver function. Our hypothesis is that a decreased synthesis of the coagulation factor levels reflects an impaired liver synthesis following hepatic resection and will be associated with poor outcomes. This is a prospective, observational study recruiting consecutive patients scheduled for major liver resection in a tertiary hospital. Coagulation profile was assessed by conventional assays, viscoelastic assays and coagulation factor levels preoperatively and, on postoperative days 1, 2 and 6...
January 31, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38305118/falsely-prolonged-prothrombin-time-test-in-a-patient-with-erythrocytosis-a-case-report
#23
JOURNAL ARTICLE
Meysam Aghajani Daronkola, Ali Dabbagh, Mahmood Shams, Shadi Tabibian, Soudabeh Hosseini, Seyed Mehrab Safdari, Akbar Dorgalaleh
The prothrombin time (PT) test is commonly used to monitor deficiencies in coagulation factors. A prolonged PT may indicate a deficiency of factors II, V, VII, X, and fibrinogen, or the presence of an inhibitor. However, further tests are required to differentiate between a true factor deficiency and the presence of an inhibitor. It is important to note that falsely prolonged PT can lead to misdiagnosis and inappropriate clinical intervention that can have life-threatening consequences. A 19-year-old woman with elevated hematocrit levels and prolonged PT was diagnosed with secondary erythrocytosis due to cyanotic congenital heart disease with ventricular septal defect (VSD)...
January 26, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38557935/lupus-anticoagulant-hypoprothrombinemia-syndrome-with-multiple-and-high-titer-antiphospholipid-antibodies-strongly-interfered-with-coagulation-assays
#24
JOURNAL ARTICLE
Motoki Sugasaki, Shingen Nakamura, Keisuke Teramoto, Minami Urushihara, Yusuke Inoue, Takayuki Nakao, Yasuhiko Nishioka, Masataka Sata
No abstract text is available yet for this article.
April 1, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38557934/sustained-good-response-to-rituximab-in-acquired-von-willebrand-syndrome
#25
JOURNAL ARTICLE
Jayna Mistry, Gillian Clare Lowe, Will Lester, Charles Llewellyn Percy
No abstract text is available yet for this article.
April 1, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38251440/diagnostic-value-of-clot-formation-parameters-determined-by-rotational-thromboelastometry-in-63-patients-with-congenital-dysfibrinogenemia
#26
JOURNAL ARTICLE
Tomas Simurda, Rita Marchi, Alessandro Casini, Marguerite Neerman-Arbez, Miroslava Drotarova, Ingrid Skornova, Jana Zolkova, Zuzana Kolkova, Dusan Loderer, Monika Brunclikova, Kristina Maria Belakova, Jan Stasko
Rotational thromboelastometry (ROTEM) is a global hemostasis assay. The diagnosis added value of ROTEM in congenital dysfibrinogenemia remains to be established. The aim of this study was to analyze clot formation by ROTEM in a cohort of dysfibrinogenemic patients and to establish correlations with genotype, clinical features, and coagulation parameters. The study included genetically confirmed congenital dysfibrinogenemia cases (n = 63) and healthy controls ( n  = 50). EXTEM, INTEM, FIBTEM tests were used to measure ROTEM parameters, that is, clotting time (CT), clot formation time (CFT), maximal clot firmness (MCF) and amplitude 10 min after CT (A10)...
March 1, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38179696/perioperative-hemostasis-management-in-patients-with-von-willebrand-disease-an-institutional-experience
#27
JOURNAL ARTICLE
Rosa Toenges, Wolfgang Miesbach, Kaja Ludwig, Beate Krammer-Steiner
OBJECTIVES: Patients with von Willebrand disease (vWD) undergoing surgery are routinely treated with von Willebrand factor (vWF)/factor VIII (FVIII) concentrate to control bleeding risk, but consensus is lacking on optimal dosing. This study aimed to evaluate the efficacy and safety of tailored doses of vWF/FVIII concentrate according to intervention-associated bleeding risk in vWD patients undergoing surgery. METHODS: This was a retrospective analysis of vWD patients who underwent surgical procedures at a haemophilia centre...
March 1, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/37994629/interpreting-coagulation-mixing-study-results-in-the-era-of-direct-oral-anticoagulants
#28
REVIEW
Moon Joo Kim, Eric Salazar, Bonnie Philips, Lawrence Rice, Brian Castillo, Christopher Leveque, Jian Chen
Interpretation of coagulation mixing studies is complicated by interference arising from direct oral anticoagulants (DOACs), which are increasingly prescribed. In this retrospective study, we reviewed 1035 consecutive coagulation mixing studies performed from 2017 to 2021. Three hundred and ninety-nine cases with normal prothrombin time (PT) and activated partial thromboplastin time (aPTT) were excluded. aPTT mixing studies were performed at time 0 and after 60 min of incubation. We confirmed the presence of interfering factors with additional laboratory testing, medication records, and medical history...
January 1, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/37994627/clot-waveform-analysis-in-acute-promyelocytic-leukemia
#29
JOURNAL ARTICLE
Malek Terras, Wijden El Borgi, Wafa Betbout, Rabeb Jaied, Fatma Ben Lakhal, Sarra Fekih Salem, Ons Ghali, Emna Gouider
The aim of this study was to evaluate the activated partial thromboplastin time (APTT) and prothrombin time (PT)-based clot waveform analysis (CWA) in patients diagnosed with acute promyelocytic leukemia (APL). APTT-based and PT-based CWA parameters of patients diagnosed with APL were analyzed and compared with healthy volunteers. Four APTT-CWA parameters were noted, maximum velocity corresponding to the first peak of the first derivative (max1), maximum acceleration corresponding to the first peak of the second derivative (max2) and the corresponding peak times of max1 and max2 (Tmax1, Tmax2)...
January 1, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/37994623/true-vs-false-immune-mediated-thrombotic-thrombocytopenic-purpura-exacerbations-a-clinical-case-in-the-caplacizumab-era
#30
JOURNAL ARTICLE
Alessandro Laganà, Silvia Maria Trisolini, Raffaele Maglione, Shafii Bafti Mahnaz, Stefano Imperatore, Diana Vitullo, Saveria Capria
Acquired thrombotic thrombocytopenic purpura (aTTP) is a medical emergency requiring urgent plasma exchange and immunosuppressive agents. Recently, the therapeutic options have been expanded by the approval of a novel anti-von Willebrand factor (vWF) nanobody, caplacizumab, inhibiting vWF-platelet aggregation. Here, we present a rare case of a patient affected by immune-mediated TTP (iTTP) reporting ischemic stroke caused by a real iTTP exacerbation during caplacizumab administration and subsequent pancytopenia caused by cytomegalovirus (CMV) infection that mimicked another iTTP exacerbation...
January 1, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38179703/double-jeopardy-glomangiopericytoma-and-glanzmann-thrombasthenia-resulting-in-recurrent-epistaxis-a-case-report
#31
JOURNAL ARTICLE
Emna Hammami, Léa Fath, Christian Debry, Dominique Desprez
Glanzmann thrombasthenia is a rare bleeding disorder induced by inherited defects of the platelet membrane αIIbβ3 glycoprotein. Glomangiopericytoma, on the other hand, is a very rare sinonasal tumor demonstrating a perivascular myoid phenotype. We herein report the first described case in the literature of Glanzmann thrombasthenia and glomangiopericytoma. The patient is a 40-year-old man diagnosed with type 1 Glanzmann thrombasthenia who presented with repetitive and profuse posterior epistaxis initially managed with platelet transfusions and recombinant activated factor VII (rFVIIa)...
December 21, 2023: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38179715/exploring-antithrombin-insights-into-its-physiological-features-clinical-implications-and-analytical-techniques
#32
JOURNAL ARTICLE
Muhammad Saboor, Hassan A Hamali, Abdullah A Mobarki, Aymen M Madkhali, Gasim Dboie
Antithrombin is an essential protein that acts as a natural anticoagulant in the human body. It is synthesized by the liver and belongs to the serine protease inhibitors, which are commonly referred to as the SERPINS superfamily. The antithrombin molecule comprises 432 amino acids and has a molecular weight of approximately 58 200 D. It consists of three domains, including an amino-terminal domain, a carbohydrate-rich domain, and a carboxyl-terminal domain. The amino-terminal domain binds with heparin, whereas the carboxyl-terminal domain binds with serine protease...
December 18, 2023: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38051647/increased-contact-activated-endogenous-thrombin-potential-in-pregnant-women-with-preeclampsia
#33
JOURNAL ARTICLE
Anne Cathrine Godtfredsen, Yaseelan Palarasah, Britta Blume Dolleris, Jan Stener Jørgensen, Johannes Jakobsen Sidelmann, Jørgen Brodersen Gram
Preeclampsia is a worldwide contributor to maternal and fetal morbidity and mortality. Women with preeclampsia are in a hyper-coagulable state with increased risk of thromboembolic disease later in life compared with normal pregnant women. The contact system (CAS) in plasma can mediate thrombin generation and is an important contributor to thrombus growth, but the activation of CAS during pregnancy complicated by preeclampsia is not yet elucidated, and CAS may play a role in the pathophysiology of preeclampsia...
December 1, 2023: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/37942747/glanzmann-s-thrombasthenia-associated-with-gastrointestinal-angiodysplasias-successfully-treated-with-bevacizumab
#34
JOURNAL ARTICLE
Agustina Saladino, María L Gonzalez, Fernando A Chuliber, Marcelo M Serra
Glanzmann's Thrombasthenia (GT) is a rare hemorrhagic condition caused by a platelet surface receptor disorder of the glycoprotein (GP) IIb/IIIa. Symptoms of GT are various forms of hemorrhages, such as purpura, epistaxis and menorrhagia. Gastrointestinal bleeding (GIB) is a rare expression of the condition and may occur due to traumas in the GI tract or as a consequence of gastrointestinal angiodysplasia (GIADs). In this case report, we present a middle-aged woman with recurrent GIB consequent to GIADs with persistent melena and iron deficiency anemia...
December 1, 2023: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/37942746/epidemiological-study-of-hereditary-hemorrhagic-disorders-in-najaf-province-iraq
#35
JOURNAL ARTICLE
Ezzate Hasson Ajeena, Ali Adil Saleem
Hemophilia and Von Willbrand disease (VWD) are the most well known types of hereditary hemorrhagic disorders (HHD). Hemophilia affects about 200 000 people worldwide, while VWD affects about 80 000. Because there is a scarcity of epidemiologic studies on hemophilia in Iraq, this study was carried out to evaluate the prevalence and incidence trends, as well as to identify some clinical and epidemiological features of hemophilia patients in Najaf province, Iraq. This study was carried out in the Najaf's hemophilia center...
December 1, 2023: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/37942745/new-score-for-predicting-thromboembolic-events-in-patients-with-atrial-fibrillation-using-direct-oral-anticoagulants
#36
MULTICENTER STUDY
Fuxin Ma, Jiana Chen, Sijie Chang, Nianxu Huang, Wang Zhang, Hengfen Dai, Qiaowei Zheng, Ruijuan Li, Xiangsheng Lin, Yuxin Liu, Xiaoming Du, Jun Su, Xiaohong Huang, Xia Chen, Wei Hu, Xiumei Liu, Yanxia Zhang, Ping Gu, Jinhua Zhang
Determinants of thrombotic events remain uncertain in patients with atrial fibrillation treated with direct oral anticoagulants (DOACs). Our aim was to identify risk factors associated with thromboembolism in patients with at atrial fibrillation on DOACs and to construct and externally validate a predictive model that would provide a validated tool for clinical assessment of thromboembolism. In the development cohort, prediction model was built by logistic regression, the area under the curve (AUC), and Nomogram...
December 1, 2023: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/37942744/combination-of-aspirin-and-rosuvastatin-for-reduction-of-venous-thromboembolism-in-severely-injured-patients-a-double-blind-placebo-controlled-pragmatic-randomized-phase-ii-clinical-trial-the-stat-trial
#37
RANDOMIZED CONTROLLED TRIAL
Christopher D Barrett, Hunter B Moore, Ernest E Moore, James Chandler, Angela Sauaia
INTRODUCTION: Venous thromboembolism (VTE) remains a significant source of postinjury morbidity and mortality. Beta-hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors (rosuvastatin) significantly reduced pathologic clotting events in healthy populations in a prior trial. Furthermore, acetylsalicylic acid (ASA) has been shown to be noninferior to prophylactic heparinoids for VTE prevention following orthopedic surgery. We hypothesized that a combination of rosuvastatin/ASA, in addition to standard VTE chemoprophylaxis, would reduce VTE in critically ill trauma patients...
December 1, 2023: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/37756208/evaluation-of-acquired-and-hereditary-risk-factors-for-the-development-of-thromboembolism-in-patients-with-systemic-lupus-erythematosus
#38
JOURNAL ARTICLE
Vildan Gürsoy, Sevil Sadri, Selime Ermurat
Although the contribution of antiphospholipid antibodies (aPL) to thrombolembolism in systemic lupus erythematosus (SLE) is well known, there is not enough data on the contribution of various hereditary thrombophilic factors. In this study, we aimed to determine acquired and hereditary thrombophilic factors in adult patients with SLE. A total of 93 SLE patients (87 women and 6 men) were included. Data on clinical, demographic and laboratory characteristics, and disease activity scores (SLEDAI) of the patients were evaluated...
December 1, 2023: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38051652/hereditary-coagulation-factor-xi-deficiency-a-rare-or-neglected-disease-results-from-a-retrospective-single-centre-cohort-in-northern-italy
#39
JOURNAL ARTICLE
Simone Canovi, Maria Cristina Leone, Luca Depietri, Maria Rosaria Veropalumbo, Annalisa Pilia, Maria Granito, Antonio Bonanno, Annamaria Casali, Rossana Colla, Angelo Ghirarduzzi
To examine real-life clinical data regarding hereditary factor XI (FXI) deficiency from a secondary care centre. Retrospective review of clinical records for every FXI:C 0.7 IU/ml or less reported from 2012 to 2020. Seventy-nine patients were included. Six (7.6%) had a severe deficiency (FXI:C <0.2 IU/ml). Only 55 (69.6%) patients were referred to the Haemostasis Centre. Among them, six (15%) were subsequently not identified at increased haemorrhagic risk before a surgical/obstetrical procedure...
November 30, 2023: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38051662/commercial-human-frozen-plasmas-for-local-cross-site-and-long-term-comparability-of-coagulation-analysers
#40
JOURNAL ARTICLE
Amélie Launois, Sara Zia Chahabi, Floriane Devaux, Isabelle Amouroux, Claire Flaujac
Laboratory compliance implies to correlate instruments for coagulation parameter with a wide range of measure using patient samples or commercialized sets of frozen plasmas. The aim of this study was to evaluate the intra, inter-reproducibility and long-term stability of ExpertCor Routine (ECR) plasma sets (Stago) on different parameters. The study was realized in two laboratories on four different instruments. Inter-site and intra-site correlation of ECR sets for PT, aPTT, Fibrinogen, INR, factor V (FV) UFH and LMWH anti-Xa and intra-reproducibility of DDimer (DDI), factor VIII (FVIII:C) and antithrombin (AT) assays were tested...
November 27, 2023: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
journal
journal
30651
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.